Hedge Fund - Harbert Management
Fennec Pharmaceuticals Inc. (FENC)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2025 - Q4 (2025-12-31) | $0 | 0% | 0 | $8.21 |
| 2 | 2025 - Q3 (2025-09-30) | $1,664,348 | 10.86% | 177,815 | $8.66 |
| 3 | 2025 - Q2 (2025-06-30) | $2,387,196 | 7.16% | 287,614 | $6.84 |
| 4 | 2025 - Q1 (2025-03-31) | $2,843,232 | 3.22% | 466,869 | $6.42 |
| 5 | 2024 - Q4 (2024-12-31) | $2,950,612 | 1.53% | 466,869 | $5.12 |
| 6 | 2024 - Q3 (2024-09-30) | $2,334,345 | 1.38% | 466,869 | $5.78 |
| 7 | 2024 - Q2 (2024-06-30) | $2,852,570 | 2.02% | 466,869 | $8.30 |
| 8 | 2024 - Q1 (2024-03-31) | $5,191,583 | 3.57% | 466,869 | $10.04 |
| 9 | 2023 - Q4 (2023-12-31) | $5,238,270 | 3.59% | 466,869 | $8.28 |
| 10 | 2023 - Q3 (2023-09-30) | $3,506,186 | 2.49% | 466,869 | $8.14 |
| 11 | 2023 - Q2 (2023-06-30) | $4,122,453 | 2.31% | 466,869 | $8.31 |
| 12 | 2023 - Q1 (2023-03-31) | $3,884,350 | 2.56% | 466,869 | $9.27 |
| 13 | 2022 - Q4 (2022-12-31) | $3,042,710 | 2.43% | 316,949 | $8.85 |
| 14 | 2022 - Q3 (2022-09-30) | $1,537,000 | 0.81% | 189,750 | $6.86 |
| 15 | 2022 - Q2 (2022-06-30) | $1,059,000 | 0.51% | 189,750 | $5.80 |
| 16 | 2022 - Q1 (2022-03-31) | $1,063,000 | 0.44% | 189,750 | $5.04 |
| 17 | 2021 - Q4 (2021-12-31) | $835,000 | 0.21% | 189,750 | $7.44 |
| 18 | 2021 - Q3 (2021-09-30) | $1,646,000 | 0.58% | 174,750 | $7.50 |
| 19 | 2021 - Q2 (2021-06-30) | $881,000 | 0.49% | 120,851 | $6.67 |
The displayed share prices are average quarterly stock market prices.
The share numbers are adjusted according to following stock splits:
-
1.0000:3.0000 on 2014-09-09
-
1.0000:18.0000 on 2011-08-31
Hedge Fund Resource Center